METASTATIC SOFT TISSUE SARCOMA
Clinical trials for METASTATIC SOFT TISSUE SARCOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SOFT TISSUE SARCOMA trials appear
Sign up with your email to follow new studies for METASTATIC SOFT TISSUE SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Triple-Drug attack aims to shrink Hard-to-Treat sarcomas
Disease control Recruiting nowThis early-phase study tests whether adding the experimental drug zanzalintinib to two immunotherapy drugs (ipilimumab and nivolumab) is safe and can shrink tumors in people with metastatic soft tissue sarcoma. About 18 adults who have already tried 1 to 3 prior treatments will r…
Matched conditions: METASTATIC SOFT TISSUE SARCOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 07:35 UTC
-
Direct-to-Lung chemo delivery aims to stop cancer spread
Disease control Recruiting nowThis study tests a procedure called pulmonary suffusion, which delivers chemotherapy drugs like cisplatin directly to the lungs through a minimally invasive method. The goal is to control any remaining cancer cells after surgery or ablation in patients with sarcoma or colorectal …
Matched conditions: METASTATIC SOFT TISSUE SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 26, 2026 07:27 UTC
-
New drug targets Hard-to-Treat sarcomas in early trial
Disease control Recruiting nowThis study tests a new drug called ADCE-D01 for people with soft tissue sarcoma that has spread or cannot be removed by surgery. The drug is designed to find and attack cancer cells while leaving healthy cells alone. About 270 adults will take part to see if the drug is safe and …
Matched conditions: METASTATIC SOFT TISSUE SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Adcendo ApS • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New hope for sarcoma: drug combo aims to slow tumor growth
Disease control Recruiting nowThis study tests a new two-drug treatment for people with advanced soft tissue sarcoma that has spread. The drugs, abemaciclib and gemcitabine, work together to stop cancer cells from multiplying. The goal is to see if this combination is safer and works better than the current s…
Matched conditions: METASTATIC SOFT TISSUE SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 18, 2026 12:00 UTC
-
Engineered immune cells take on hard-to-treat sarcomas in early trial.
Disease control Recruiting nowThis early-stage trial tests a new treatment called attIL12-TIL for people with advanced or metastatic soft tissue and bone sarcomas. The therapy uses a patient's own tumor-fighting immune cells, modified to better target and attack the cancer. The study first finds a safe dose, …
Matched conditions: METASTATIC SOFT TISSUE SARCOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 18, 2026 11:59 UTC